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Iron oxide nanoparticles (IONPs) have been investigated enormously in bio-application field 
including MRI contrast image, cancer cell targeting, biological sensing, and drug delivery. All these bio 
applicable IONPs require highly monodisperse size, biocompatibility, and long term colloidal stability 
in aqueous media. 
The synthesis of high quality IONPs was reported in the previous study. However, these uniform 
sizes of IONPs are constructed with hydrophobic ligand because they are synthesized in oil phase. In 
addition, IONPs for bio application, the surface modification step is essential. There are two main 
surface modification methods, ligand exchange and encapsulation with amphiphilic polymers, have 
been employed to produce water dispersible and biocompatible IONPs. Although encapsulation process 
is easy, rapid, and reproducible, there are limitations of poor purification of polymer micelle structure 
and increase in hydrodynamic diameter size. In this research, to overcome these limitations, ligand 
exchange with random copolymer which was synthesized by RAFT polymerization was used to 
synthesize highly compact and robust water dispersible IONPs. 
After 12 nm of IONPs were ligand exchanged with optimized ligand, these were maintained compact 
HD size about ~15±4 nm with high yield and reproducibility. Although their colloidal stability was 
established, functionalization of IONPs and stability in further reactions to conjugate bio molecules 
were required. To achieve these requirements, ‘cross-linking’ using various length of diamine was 
investigated in this research. Cross-linking reaction proceeded by EDC coupling of diamine and 
carboxyl group of IONPs surface ligand. From this process, highly enhanced colloidal stability of 
IONPs and functionalization of amine group were expected. To confirm the cross-linked nanoparticles 
(CLNPs), XPS spectra and visualization with TEM analysis were performed. CLNPs enhanced stability 
was compared with PEG dominant ligand (IONPs-PEG) and acid included ligand (IONPs-AA) 
composed IONPs by broad range of pHs, NaCl solution, temperature, purification effects and ‘click 
chemistry’ condition. These were evaluated by changes of each conditions of IONPs sizes with DLS 
analysis. Furthermore, as available functionalized amines of CLNPs were observed by RITC 
conjugation, tried to conjugate two different bio molecules. One is mannose carbohydrate conjugation 
was proceeded and confirmed with HR-MAS analysis and FT-IR. Also, MR relaxivity was measured 
by concanavalin A (Con A) mannose selective binding lectin to confirm conjugated mannose was 
retained their property. The other approach was folic acid conjugation. With folic acid conjugated 
CLNPs (CLNPs-FA), in vitro test was performed. HeLa cell which have lots of folate receptor on their 
surface was used to evaluate CLNPs-FA targeting ability. The result of targeting was observed with 
Prussian blue staining of HeLa cell. 
Through this research, compact and robust ligand and cross-linking conditions were optimized and 
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confirmed various tool. At the same time, amine functionalization of IONPs were accomplished with 
facile method simultaneously. This ligand and cross-linking methods have great potential to be applied 
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1.1 general properties of iron oxide nanoparticles 
 
Iron oxide nanoparticles (IONPs) are superparamagnetic materials, such IONPs have 
properties of low toxicity and biocompatible. Because of these properties, they have been of great 
interest in MRI reagent, cell targeting and drug delivery (Figure 1)1-2. Especially for bio application 
of IONPs, synthesize monodisperse nanoparticles were studied in decades3. Highly monodisperse 
IONPs are essential property in bio application. Because, the size of IONPs affects cellular uptake, 
and bio distribution when injected in vivo4. The size of IONPs should be optimized to avoid rapid 
excrete by the immune system, and consequently to be accumulated in the target tissue. It was 
reported that small-sized nanoparticles (e.g., hydrodynamic diameter (HD) of < ~10 nm) are likely 
to be excreted. Meanwhile, large particles (e.g., HD of > ~100 nm) are taken up by phagocytes, 
and therefore tend to accumulate in tissues. In the case of medium sizes of particles (e.g., HD of 
20-100 nm) have long circulation time in body, and they’re suitable size to be accumulated through 
enhanced permeability and retention (EPR) effect to cancer cell vasculature which are hundreds of 
nanometers5. It is well known that the magnetic properties of IONPs depend on the particle size. 
Unless the IONPs have superparamagnetic characteristics, if there is no external magnetic field, 
IONPs have no magnetic properties because the magnetic moment of IONPs become randomized 
by heat energy. However, if the external magnetic field is applied, the magnetic moments of the 
particles are arranged in a certain direction by the external magnetic field and exhibit strong 
magnetic behaviors6. The IONPs have a surface-to-volume ratio, so the spin canting effect is not 















1.2 Surface modification of IONPs 
 
Most effective synthetic process of monodisperse and high quality IONPs is based on high 
temperature reaction of organometallic precursors. Synthesized IONPs with this approach are 
mainly dispersed in hydrophobic solvents because they are capping with water-immiscible ligand8. 
Because IONPs are usually applied in bio field, they are required to be dispersed in hydrophilic 
solvents. To accomplish this requirement, surface modification process of IONPs are necessary, 
and this surface modification field was researched in many decades. For example, representative 
surface modification methods are encapsulation9, silica coating10, and ligand exchange11-13 methods 
are studied for a long time (Figure 2). 
First, the encapsulation method has advantages of simple, reproducible, and rapid without any 
surface treatment. Individual IONPs could be encapsulated in the hydrophobic core of a micelle 
composed of a mixture of hydrophobic alkyl chain and poly(ethylene glycol) PEG as a hydrophilic 
part called polysorbate 809. In addition, PEG is widely used because that is poorly immunogenic 
and antigenic and acts as excellent repellent for biomolecules. Another research, Johnson, He et al. 
which used PEGylated phospholipid (DSPE-PEG) micelles to coat NaGdF4 NCs for bio 
application14. Through this approach, they controlled the micellization of NPs, then achieved 
compact NC-micelles with ultrahigh T1 relaxivity. On other hand, encapsulation method has 
limitations of relatively weak colloidal stability in organic solvents, and the purification step of 
micelles without any NPs is difficult to optimize. 
The second most commonly used coating method is silica coating. Silica is well known water 
soluble and quite biocompatible materials. Owing to these properties, It has a great potential of 
resist ant to biodegradation, moreover, it can be easily constructive for functionalization of NPs for 
bioconjugation and targeting in biological systems15. For example, Lu, Hung et al.15 developed 
fluorescein isothiocyanate (FITC) incorporated silica-coated IONPs. However, If NPs surfaces 
treated with silica coating, the size of IONPs will increased by their thick shell. It may affect lower 
the MR contrast image because silica coated IONPs have low water access. 
To accomplish thin layered, compact, and robust surface modification method, ligand exchange 
of IONPs were studied in many researches12, 16. Jun, Huh et al17. used a simple but highly effective 
2,3-dimercaptosuccinic acid (DMSA) ligand for IONPs surface modification. The DMSA forms a 
stable coating through carboxylic bonding and further stabilization is attained through 
intermolecular disulfide bond between the ligands under ambient conditions. The remaining free 
thiol groups of DMSA are used for the attachment of target biomolecules. Other approach of ligand 
exchange method is using phosphine ligand conjugated PEG chain (PO-PEG)18. The synthesis of 
PO-PEG is extremely facile, thus it’s practical for the large scale preparation of dispersed IONPs. 
And the last, water soluble zwitterionic dopamine sulfonate ligand was used for surface 
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modification of hydrophobic IONPs19. Because dopamine catechol part has a strong binding 
affinity with surface of IONPs, this property gives IONPs as compact and highly stable in water 
dispersible conditions by sulfonate group of the zwitterionic ligands. However, even these 
monomeric ligand exchange methods give highly stable in aqueous media, IONPs required more 
stability for further reaction such as bio conjugation. To overcome this limitation, the formation of 
dimer, polymer structures of ligands were used for surface modification12, 20. Polymer is consists of 
several anchor monomers in backbone, this structure enhances probability of ligands to binding 
IONPs surface. These features improve IONPs colloidal stability in high temperature, and wide 









Figure 2. TEM image of (a) encapsulated NaGdF4 nanoparticles14. (b) silica coated IONPs15. (c) IONPs 
ligand exchanged with water dispersible zwitterionic dopamine sulfonate monomer19. (d) IONPs ligand 




1.3 Colloidal stability approaches of IONPs 
 
As NPs are highly increased in applications of chemistry and biology, applications usually 
require that the IONPs are well dispersed and stable against aggregation in a liquid condition21. The 
relationship between aqueous media and colloidal stable NPs is very important for application in 
the human body22. As mentioned in several researches, steric and electrostatic repulsion between 
NPs are essential property for achieving good colloidal stability. Also, good surfactants can provide 
stabilization of NPs. 
To enhance the stability of IONPs in aqueous media, researches tend to modify anchor or spacer 
group of the water dispersible ligand. Sterically stabilized IONPs are achieved by two general 
method22, first approach is that dispersants consist of repeated unit with low affinity have possibility 
of encapsulate several cores together, which derives increase of size. The weak affinity of the 
stabilizing polymer dispersants reduces iron oxide NP stability23, protein adsorption to NPs 
occurred and extremely decreases blood circulation time24. Because the size of NPs become large, 
the alternative approach is that using with low Mw spacer and high affinity anchor groups which 
is covalently linked together. In this case, dispersants constructed like brushed structure, NPs 
stability can be enhanced relatively with compact size. However, these processes have limits of 
stability in long term, to overcome the limitation ‘cross-linking’ was considered as alternative 
method. 
The cross-linking is that the tight binding of ligands on the surface of NPs to prevent ligand 
detachment. cross-linked iron oxide nanoparticles (CLIO) had been developed25, and they are 
composed of chemically cross-linked dextran coated IONPs26. These synthesized CLIOs are 
considered as the most effective MR contrast agents because of their stable coating, and compact 
hydrodynamic size27-28. Also, cross-linked NPs with biocompatible polymer or dendrimer had been 
reported29. For example, Jon et al.30 reported thermally cross-linked superparamagnetic iron oxide 
nanoparticles (TCL-SPION) which cross-linked with thermal reaction of Si-OH containing 
copolymer unlike chemical cross-linking system30. In this research, they used denoted as poly-
(TMSMA-r-PEGMA) random copolymer, it consists of ‘surface anchoring moiety’ (silane group) 
and a ‘protein-resistant moiety’ (PEG). Highly stable polymer coating was performed, PEG-silane 
copolymer became cross-linked as hydrolyzation of silane groups (-Si(OH)3) by simple heat 
treatment. Furthermore, functionalization of TCL-SPION was performed simultaneously (figure 
3a). The other approach for cross-linking was reported by Kim et al.31 they developed cross-linked 
polymeric nano assemblies by cross-linking of poly(succinimide) (PSI) with hexamethylene-
dimaine (HMD) linker (figure 3b)31, and they were successfully prepared to show strong potential 
for bio-applications. 
Through these cross-linked magnetic nanoparticles were developed to improve the structural 
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stability of amphiphilic polymer coated magnetic nanoparticles. These nanoparticles show strong 









Figure 3. Scheme of (a) poly(TMSMA-r-PEGMA-r-NAS) (top), carboxyl TCL-SPION showing 
crosslinking between polymer layers after heat treatment (bottom)30. (b) cross-linked magnetic 




1.4 IONPs in bio application 
 
In bio-application, surface functionalized magnetic iron oxide nanoparticles (IONPs) are a kind 
of novel functional materials32. The bio-applications of IONPs are known Magnetic resonance 
imaging (MRI) contrast agents33-35, cancer cell targeting36-37, and magneto responsive therapy38-39 
(figure 1)1. 
IONPs are the most appropriate substances which can be alternative MRI contrast agents 
because of their high biocompatibility. To obtain a magnetic resonance signal, IONPs are placed 
in a strong magnetic field (B0). When a resonant radiofrequency is irradiated, the nucleus absorbs 
the energy and the number of the spins with a higher-energy state increase25, 40. Then, the nuclei 
return to the equilibrium state, it is referred to as relaxation. There are two types of relaxation 
processes, The T1 relaxation time represents the time required for longitudinal magnetization to 
recover from zero to a value of 63% of the original state. The T2 relaxation time represents the time 
for the transverse magnetization to drop from the maximum to a value of 37% of its excited state41. 
Although IONPs affect both the longitudinal and transverse relaxation processes, they’re mostly 
used in T2 relaxation. Because the T2 contrast effect is highly dependent on the magnetization of a 
particle, the r2 values can be increased by enhancing the magnetic moment of a nanoparticle or 
clustering of nanoparticles1, 41-42. 
There have been many studies on cancer cell targeting using IONPs43-46. There are two 
approaches in cancer cell targeting, one is active targeting and the other is passive targeting. First, 
the passive targeting is processed with EPR effect when nano sized up to 100 nm of NPs were used.  
This phenomenon is caused by accumulation of leaky vasculature of tumor cell47. However, NPs 
large size of NPs are hard to penetrate into the dense tissue matrix. To overcome this limit, Wong, 
Stylianopoulos et al.47 introduced multistage nanoparticles concept to IONPs of passive targeting. 
100 nm nanoparticles separate to 10 nm nanoparticles after they excrete from leaky vasculature of 
the tumor. Another approach of targeting is the active targeting which requires bio molecules such 
as glucose or folic acid of targeting reagent. Immobilized targeting ligand recognizes receptors 
over expressed on the exterior surface of cancer cells48. G. Chen et al. reported the development of 
magnetic and folate (FA)-modified cell-derived microvesicles (MVs) which exhibited significantly 
enhanced antitumor efficacy both in vitro and in vivo46. It indicates active targeting method is 




II. Compact and cross-linked nanoparticles: nano platform for highly 




Superparamagnetic iron oxide nanoparticles (IONPs) have great potential in bio application 
because of their adequate properties for bio media such as low toxicity and biocompatibility22. In 
addition, they have been researched in various field for decades, for example, magnetic resonance 
imaging (MRI)6, 41-42, 49, drug delivery1, 50, cell labeling4, 51, separation43, 52, tracking53, and 
hyperthermia54. For IONPs in these representative bio applications, monodisperse, good dispersity, 
low toxicity and colloidal stability properties are required in biological media41. In previous 
researches, it has been widely known to synthesize high quality of metal oxide with uniformity and 
crystallinity in organic solvent3. However, as these highly monodisperse nanoparticles are 
composed of hydrophobic ligand, it is difficult to disperse in the water and bio application is not 
possible. Therefore, surface modification of nanoparticles (NPs) is essential. There have been 
various surface modification methods for water-dispersible NPs4, 46, 51. The most commonly used 
methods are silica coating55, encapsulation56, and ligand exchange57. Although water-dispersible, 
stable, and biocompatible NPs are synthesized through these facile modification methods, these 
NPs formed as large sizes because of their thick shell coating, also, there are limits such as low 
surface coating yield, low reproducibility and stability. Since the colloidal stability is a most 
important issue in bio-applications, high stability is the most required factor. To be used in bio 
media, NPs should be stable enough to withstand wide range of pHs, stain in nonspecific binding 
by protein, and long circulation in human body. 
In order to satisfy both of these limitations and requirements, a ‘Cross-linking’ method was 
introduced into the water-dispersible NPs. Cross-linking is simply a way to tightly ligate the ligands 
on the surface of NPs. 31, 53, 58. In previous research, cross linked iron oxide nanoparticles (CLIO) 
using dextran was developed before, these are used in T2 MRI agent because they are biocompatible, 
and relatively monodisperse. However, because they’re synthesized with co-precipitation method, 
they have low contrast effect. Also, they must be functionalized through a complicated process with 
chemical reaction which has toxicity in vivo system. To overcome these limitations, cross-linking 
system was applied to the monodisperse IONPs ligand exchanged with biodegradable polymers. 
Recently, IONPs modified with poly(succinimide) (PSI) were cross-linked with 
hexamethylenediamine (HMD) research was reported, although they’re stable and biocompatible, 
the 12 nm of cross-linked IONPs size was increased to 45 nm, and they have low reproducibility. 
In advance of cross-linking aspects, there was no significant evaluation factors and confirmation 
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of cross-linked nanoparticles. 
In this research, a polymer ligand was optimized by RAFT polymerization for compact and 
robust water dispersible IONPs, and cross-linking reaction was proceeded with diamine and 
carboxyl on surface was conjugated by EDC coupling reaction. Furthermore, studied effect of 
cross-linking by using different lengths of diamines and various addition equivalents. To confirm 
cross-linked nanoparticles, XPS spectra was used and visualization of CLNPs was attempted by 
TEM analysis with negative staining method. Moreover, highly enhanced stability of CLNPs were 
performed by wide range of pHs and NaCl, temperature effect, purification step and ‘click 
chemistry’ condition which is known as harsh environments for NPs. At the same time, with 
diamine cross-linking process, the amine group expected to be functionalized on CLNPs surface. 
Through confirmation of free amine group of CLNPs, bio molecule conjugate experiments were 
performed using mannose and folic acid. To confirm conjugation of bio molecules, HR-MAS, FT-
IR, and UV-Vis were analyzed. Finally, to evaluate their bio abilities were retained after CLNPs 
conjugation, MR relaxivity measure and in vitro test were performed. Through these results, the 
highly stable and multifunctional nanoparticles were synthesized through facile diamine 




2.2 Experimental methods 
 
2.2.1 Materials 
Iron chloride, sodium oleate, oleic acid, 1-octadecene, acrylic acid, poly(ethylene glycol) 
methyl ether acrylate, 2-(2-aminoethoxy) ethanol (AEE), 1-ethyl-3-(3-dimethylaminopropyl) 
carbodiimide hydrochloride (EDC) were purchased from Sigma-Aldrich. N-
hydroxysulfosuccinimide (sulfo-NHS) was purchased from TCI. 10x phosphate buffer saline was 
purchased from Biosesang. Dopamine methacrylamide were synthesized as previously reported59. 
 
2.2.2 Instrumental and analysis 
1H NMR spectra were recorded using a 400 MHz Brucker spectrometer. Residual proton 
signal of deuterated solvent was selected as the reference standard. The HR-MAS proton spectra 
were recorded on a 700MHz FT-NMR Spectrometer (Western Seoul Center, Korea Basic Science 
Institute). The Size and morphologies of nanoparticles were studied by transmission electron 
microscopy (TEM, JEOL, JEM-2100) which was operated at 200 kV. Dynamic lignt scattering 
(DLS) measurements were performed on a Malvern Instruments Zetasaizer Nano-ZS90 at 25 °C. 
Gel Permeation Chromatography (GPC, Shimadzu, eluent; THF) was used for measure molecular 
weight of synthesized polymer. X-ray photoelectron spectroscopy (XPS) spectra were performed 
in UCRF. UV-Vis spectra (Shimadzu UV-1800) were taken with a quartz cuvette. Infrared (IR, 
Varian 670/620) were measured at room temperature with Ar inert atmosphere. Magnetic relaxivity 
was measured with minispec (Brucker) at 37 °C. For purification of excess ligand or molecules, 
fast protein liquid chromatography (FPLC, GE healthcare) and G-25 sephadex column were used. 
 
2.2.3 Synthesis of iron-oleate complex 
The metal–oleate complex was prepared by reacting metal chlorides and sodium oleate. To 
synthesize iron–oleate complex, 5.4 g of iron chloride (FeCl3·6H2O, 20 mmol) and 18.3 g of 
sodium oleate (60 mmol) was dissolved in a mixture solvent composed of 40 ml ethanol, 30 ml 
distilled water and 70 ml hexane. The resulting solution was heated to 70 °C and kept at that 
temperature for 4 hours. When the reaction was completed, the upper organic layer containing the 
iron–oleate complex was washed at least 3 times with 15 ml distilled water and 10 ml ethanol 
solvent in a separatory funnel. Resulting in iron–oleate complex in a waxy solid form. 
 
2.2.4 Synthesis of iron oxide nanocrystals 
The following procedure is optimized for synthesis of monodisperse iron oxide (magnetite) 
nanocrystals with 12 nm particle size. 0.9 g (1 mmol) of the iron-oleate complex synthesized as 
described and 0.2 g of oleic acid (0.73 mmol) were dissolved in 1.5 g of 1-octadecene (90%) at 
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room temperature for 1 hour. The reaction mixture was heated to 320 °C with a constant heating 
rate of 3.3 °C min-1 in Ar inert atmosphere, and then aging the mixture at that temperature for 30 
min. After the reaction is over, the solution containing the nanocrystals was then cooled to room 
temperature with Ar purging. To get the solution to precipitate the nanocrystals, acetone:ethanol 
3:1 solvent was added. The nanocrystals can be separated by centrifugation. 
 
2.2.5 Synthesis of ligand by RAFT polymerization 
To synthesize the ligand we used RAFT polymerization method. 0.13 g of dopamine methacryl 
amide (0.6 mmol), 0.04 g of acrylic acid (0.6 mmol) and 0.4 g of poly(ethylene glycol)480 (0.8 
mmol) were dissolved in dimethylformamide (DMF). 0.03 g of dibenzyl trithiocarbonate RAFT 
agent (0.1 mmol) was prepared. To afford a controlled living polymerization, 8 mg of radical 
initiator agent azobis(2-cyanopentanoic acid) AIBN was added (0.05 mmol). The mixtures of 
monomers transferred to the 4 ml ampule. The ampule was subjected to 3 cycles of freeze-pump-
thaw, and sealed under vacuum condition using a torch. The ampule was heated to 70 °C on an oil 
bath for overnight. After the reaction is over, synthesized polymer was washed with diethyl ether 
(Aldrich, 99.5%) to remove unreacted monomers. Excess solvent was dried under vacuum oven 
for 12 hours. 
 
2.2.6 Ligand exchange of 12 nm IONPs 
Ligand exchange was carried out in a 5 ml vial. Prepare 10 mg of 12 nm IONPs dispersed in 
1 ml of tetrahydrofuran (THF) solvent. 0.04 g of polymerized ligand (0.05 mmol), and 0.2 g of 
coating reagent 2-(2-aminoethoxy) ethanol (0.95 mmol) were mixed together with prepared THF 
dispersed IONPs in 5 ml vial. The ligand exchange reaction was heated to 60 °C on an oil bath for 
12 hours. The product was washed with diethyl ether in 50 ml falcon tube, then the precipitates 
were obtained by centrifugation. Excess solvent was removed in vacuum oven, then dispersed in 
1xPBS. The excess ligand and CR reagent were purified by fast protein liquid chromatography 
(FPLC) G-25 sephadex column. 
 
2.2.7 Cross linking of IONPs (CLNPs) 
Cross linking reaction was achieved through amide bond by EDC/Sulfo-NHS reaction with 
carboxyl group on the IONPs surface using diamine. The amount of diamine added was set at 
various ratios to the carboxyl group on the surface. The reaction was held in the total IONPs 
concentration was set to 0.3 mM. EDC/Sulfo-NHS pre-activation step of water dispersed IONPs 
was held about 1 hr in thermos mixer 1000 rpm, then several ratios of diamine dissolved in water 
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was added. The total reaction volume was 1 ml. After the reaction, excess EDC/Sulfo-NHS and 
diamine were removed by viva spin cut off 50k. 
 
2.2.8 Conjugation of rhodamine B isocyanate to CLNPs 
To quantify the number of functionalized amine group of CLNPs, we used RITC conjugation 
and analyzed by UV-Vis absorbance. Prepare CLNPs dispersed in pH 9 buffer solution, then RITC 
dissolved in DMSO solution was added as 1 equivalent of the expected carboxyl group on the 
CLNPs surface. 
 
2.2.9 Synthesis of maleimide propionic acid 
To synthesize the linker maleimide propionic acid, add 2.699 g of β-alanine (30.3 mmol) into 
2.903 g of maleic anhydride (29.6 mmol) dissolved DMF solution. The mixture was stirred for 2 
hr at RT. Lower the temperature of the mixture to 0 °C with ice bath. Add 4.255 g of NHS (37 
mmol) and 12.98 g of DCC (63 mmol) to the mixture, then stirred at RT vigorously overnight. 
Filtered white precipitates then evaporates solvents totally. Dissolve the product in DCM, extract 
the product with DI water. Concentrate the product with evaporator and purify it with column. 
 
2.2.10 Conjugation of mannose 
Disperse amine functionalized CLNPs in 250 ul of DMF solution. Add DMF dissolved 
maleimide propionic acid as 1 equivalent ratio relative to amine group of CLNPs. Total reaction 
volume was 500 ul in micro tube, react with thermo mixer 4 hrs. add the 1 equivalent of acetyl 
protected mannose was dissolved in 250 ul of DMF to the mixture for overnight at RT. To make 
basic condition, add 10 ul of triethylamine. To purify excess maleimide propionic acid linker and 
mannose, dialysis process in pH 11 buffer solution was required. At the same time, DMF solvent 
was exchanged with pH 11 buffer and acetyl group was deprotected. 
 
2.2.11 Conjugation of folic acid 
To conjugate folic acid to amine functionalized CLNPs, prepare 1 equivalent ratio of folic acid 
relative to concentration of CLNPs in 1xPBS (pH 7.4) solution. Pre-activation of folic acid was 
proceeded with excess amount of EDC/Sulfo-NHS for 1 hr. CLNPs dispersed in 1xPBS were added 
into activated folic acid solution, the reaction was taken for overnight at RT. To purify excess 
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reagents, FPLC (sephadex G-25) was used. 
 
2.2.12 MR relaxivity 
To measure the relaxivity of CLNPs-Man, concentration of 0.6 uM CLNPs-Man were prepared. 
The sample was prepared total volume of 300 ul and volume of additive Con A (0.01 mg/ul) was 
set as 0, 10, 30, 50, 100 ul. CLNPs-Man sample and Con A solution were mixed in T-tube for 1 
min then transferred to the MR relaxivity analysis tube. Same procedure was applied to IONPs. 
 
2.2.13 Cell culture and preparation 
HeLa cells are cultured in using DMEM media supplemented with 10% Tet approved FBS and 
1X pen/strep, wash cells with PBS buffer 1 time and add 2 ml of Tryple solution to the cells. Then 
incubate HeLa cells for 2 min at 37°C. Then add 5 ml of complete media to the HeLa cell solution. 
Finally replate cells at a 1:20 dilution in 24 well plates. 
 
2.2.14 Prussian blue staining 
HeLa cell lines were incubated in 12-well plate. CLNPs-FA were treated in HeLa cell a final 
concentration of 200 and 500 µg/mL per well. After 6 hr, cells were washed three times with PBS 
solution, then CLNPs conjugated HeLa cells were treated with 0.5 ml of 10% formalin solution for 
5 min to fixation step, and then washed with PBS. Prussian blue staining was then performed. To 
each well was added a 1:1 mixture of 4% potassium ferrocyanide(II) trihydrate and 2% HCl 
solution (0.5 mL), and cells were incubated for 15 min, counterstained with nuclear fast red for 3 




2.3 Results & Discussion 
 
2.3.1 Synthesis of ligand & water dispersible IONPs 
Iron oxide nanoparticles (IONPs) of uniform size (12 nm) are synthesized as previously 
reported3 (figure 4a), IONPs are capped with a hydrophobic ligand because they are synthesized in 
the oil phase. Hydrophilic properties are required for bio-application of IONPs. To impart 
hydrophilic properties to the IONPs, we used compact and robust ligand exchange method. The 
ligand used in this research was synthesized as random copolymer through RAFT polymerization 
(scheme 1). To design appropriate polymer for water dispersible IONPs, dopamine methacrylamide 
(DMA) was used as an anchor group binding to the surface of IONPs, poly(ethylene glycol) (PEG 
mw. 480) was used as hydrophilic chain part, and the carboxyl functional group was obtained by 
adding acrylic acid monomers. To optimize the composition of these ligands, length of ligand, ratio 
of carboxyl group and anchor group (DMA) were considered while polymerization. Each polymer 
synthesized under these conditions was characterized by gel permeation chromatography (GPC) 
and nuclear magnetic resonance (NMR). To determine if the exchanged ligand was suitable, we 
measured particle size changes with dynamic light scattering (DLS) (figure 5).  
First, as polymer DP were set to 20, 50, and 100, it was expected that polymer would cover 
IONPs as the length became longer. However, IONPs were aggregated as the length became longer. 
This result is due to the stability of the IONPs decreased due to the interaction between fast protein 
liquid chromatography (FPLC) column during purification process when long polymer is used 
(figure 5a). As a result, polymer DP was fixed at 20 as normally it was. The ratio of carboxyl group 
added to the ligand was set to 10, 20, and 30%, then observed size change of IONPs after ligand 
exchange. As a result, the stability of the particles was found to decrease as the ratio of carboxyl 
group decreased (figure 5b). This is because the negative charge ratio of carboxyl is increased and 
charge repulsion is formed, which makes more stable in water dispersion. Also, partial of 
carboxylic acid tends to bind to the surface of IONPs that helped the ligand to be attached better to 
IONPs. Finally, the stability of the IONPs was confirmed by increasing the anchor group, DMA 
addition ratio to 30, 40, and 50%. As the result of DLS measurement, it was observed that compact 
size was maintained under all conditions (figure 5c). For further comparison of these results, we 
confirmed the stability of each ligand exchanged IONPs in a harsh ‘click’ chemistry condition 
(Figure 5d). As a result, DMA 30% PEG480 40% Acrylic acid 30% ligand exchanged IONPs did 
not become degradation and were stable even after 1 week. This is because the hydrophilic and 
acid functional parts were polymerized in an appropriate rate. Therefore, the optimal ligand 
composition to be used in this research is DMA 30% PEG480 40% Acrylic acid 30% (scheme 2). 
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When the ligand exchange was performed using the optimized ligand, the absence of 
aggregation was confirmed by transmission electron microscopy (TEM) (figure 4b) and DLS 
(figure 4c). This compact and robust water dispersible IONPs have been synthesized, but still need 










Figure 4. TEM image of IONPs (a) before ligand exchange and (b) after ligand exchange. (c) DLS data 















































































Figure 5. DLS data after ligand exchange and purification step (a) DP adjustment. (b) ratio control of 
acrylic acid group. (c) ratio control of DMA the anchor group. (d) camera image of IONPs after click 



















Scheme 2. Scheme of the optimized ligand for ligand exchange of Fe3O4 iron oxide nanoparticles 
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2.3.2 Cross linking with various diamines 
Various bio-molecule conjugation and purification steps are essential for the application of 
water dispersible IONPs to bio-fields. Since the chemical reaction process is inevitable in the 
conjugation process, IONPs may be unstable at this part. To overcome this limitation, we enhanced 
the stability of ligand exchanged IONPs with cross-linking the surface ligands by EDC coupling 
with diamine (scheme 3). 
In this research, three diamines used for cross-linking, ethylene diamine (EDM), 
hexamethylene-diamine (HDM), and Bis(hexamethylene) triamine (BHTM) were selected to 
compare the colloidal stability and expression level of amine functional group of cross-linked 
IONPs (CLNPs) (figure 7). First, IONPs surface activation was performed by setting the amount 
of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride (EDC) and N-
hydroxysulfosuccinimide (sulfo-NHS) to be compared with the expected amount of carboxyl group 
on the surface of 12 nm IONPs that had been modified with optimized ligand. The amount of 
diamine added was summarized (table 2, figure 8). The reason why the amount of diamine added 
to IONPs was set to at least 125 equivalents (eq.) is when the diamine was added above 100eq. of 
carboxyl group, there was no enhancement in colloidal stability. After cross-linking reaction, 
hydrodynamic diameter (HD) of CLNPs were measured with DLS to confirm the size of the CLNPs 
were maintained after reaction. As shown in the Table #, all the diamine conditions maintain 
compact HD CLNP size (~ 25 ± 5 nm). Also, analysis of zeta potential of CLNPs were required to 
compare extent of cross-linking reaction by various concentrations of diamines. As a result, the 
zeta potential value of CLNPs with hexamethylene diamine was found to be the least neutral (~ -
19 ± 2 mV) because the carboxyl group and both amine was coupled well, so it means that cross 
linking with HDM has been done well in this condition. On the other hand, in the other diamine 
conditions, the CLNPs charges were found to be quite neutral. The reason for this is presumably 
because the diamine is not used for all cross-linking, and one amine moiety have been expressed. 
To approve the assume that the HDM was well conjugated as cross-linking reagent, and the 
others are suitable for functionalization of amine group, the number of functionalized amine group 
in CLNPs was calculated by rhodamine B isocyanate (RITC) conjugation. RITC dye can be 
detected by UV-Vis spectroscopy, it has absorbance at wavelength 558 nm, then the conjugated 
RITC can be calculated by integrating the normalized UV graph (figure 9). First, cross-linked with 
HDM, it shows the lowest number of accessible amine (figure 10). This can be interpreted as both 
amine of HDM was well conjugated to carboxyl group of the surface. Unlike this result, the other 
diamines show increased number of amines compared to HDM. 
To confirm that cross-linked using HDM enhanced stability of CLNPs, we observed colloidal 
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stability test of each diamine cross-linked conditions in pH 3 buffer solution (figure 11). As shown 
in the camera image, it seems to be maintain stable in all diamine conditions for 1 week. However, 
the size distribution of each CLNPs measured by DLS, interprets that CLNPs are stable under most 
conditions except cross-linked with 125 eq. of ED. The highly stable CLNPs were cross-linked 
with 250 eq. of HDM. Through these results, diamine cross-linking which enhances the stability of 




























Table 2. Hydrodynamic diameter (nm) and zeta potential (mV) values measured by DLS which used 
































































































































Figure 9. Confirmation of amine functionalized CLNPs with RITC UV-Vis absorbance at wavelength 





















































Figure 11. Camera image of stability test in pH 3 of CLNPs with (a) EDM (c) HDM and (e) BHTM. 






2.3.3 Confirmation of cross linked IONPs (CLNPs) 
To ensure the cross-linking reaction was applied to IONPs appropriately, confirmation was 
made using CLNPs with 250 eq. of HDM by X-ray photon spectroscopy (XPS), TEM analysis.  
First, TEM analysis was attempted for the visualization of the presence of the CLNPs (figure 12). 
To visualize organic polymers with TEM, the negative staining with 2 wt% of phosphotungstic acid 
method is mainly used31. Prior to visualization experiments, CLNPs polymer was expected to 
maintain particle size. For TEM analysis, etched IONPs and CLNPs with 4 M of HCl solution were 
prepared, then extracted polymer by chloroform solvent. The negative stained of the extracted 
polymer was confirmed by TEM. As a result, the cross-linked polymer was found to maintain larger 
size than uncross-linked polymer (figure 12). This suggests that some of the ligands bound to the 
surface of CLNPs may be retained. Also, by DLS measurement, the size of IONPs polymer was ~2 
nm but the CLNPs polymer was maintained larger size (figure 12e). The reason for this 
phenomenon is that when the polymer ligand has a certain concentration or more, it forms a 
spherical shape of micelle, so that the polymer without cross linking could be maintained as 
spherical when it was confirmed by TEM. 
XPS spectra was used to make quantitative and reliable confirmation of CLNPs. IONPs and 
CLNPs were prepared for comparison of cross-linking reaction (scheme 4). N1s and C1s peak of 
each NPs were analyzed for comparison of difference between the presence of cross-linking (figure 
13). First, comparing the N1s peak of NPs (figure 13c,d), before cross-linking, the amide bond of 
DMA and the amine bond of coating reagent (CR) amino ethoxy ethanol (AEE) were confirmed 
by XPS peak 399.5 eV, 398.2 eV60. However, 401.8 eV. peak was detected in CLNPs XPS spectra 
which represents the primary amine peak from cross-linked HDM. As the primary amine peak is 
formed, the CR amine peak is relatively decreased and the amide bond peak of diamine and 
carboxyl is increased. As a result, it can be shown that amide bond is formed due to EDC coupling. 
At the same time C1s XPS peak was analyzed (figure 13a,b). for the comparison with each NPs, 
the C1s XPS spectra was performed by normalization based on PEG C-O ether group. When 
diamine was used for cross-linking reaction, the content of C-C/C-H bond is increased from 108.7% 
to 185.6%. This result indicates that the HDM was involved in cross-linking of IONPs by EDC 









Scheme 4. Scheme of the (a) IONPs-AA and (b) CLNPs with 125 eq. of HDM to compare N1s and C1s 
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Figure 12. Visualization of polymer with 1 wt% of phosphotungstic acid, IONPs polymer by TEM 
magnification (a) 50 k and (b) 100 k, CLNPs polymer in (c) 50 k and (d) 100 k. (e) DLS data of these 































Figure 13. XPS spectra of C1s peak fitting of (a) IONPs and (b) CLNPs with HDM. N1s peak fitting 
of (c) IONPs and (d) CLNPs  
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2.3.4 Various stability test of CLNPs 
The greatest advantage of the cross-linking is that the stability of the IONPs is maximized. 
Research on colloidal stability of bio-application nanoparticles has been done for many years13, 56, 
61. Although there have been many studies of enhancing stability, there have not been many reports 
on the validation of colloidal stability. In this research, various verification tools for the colloidal 
stability were proposed and the stability of CLNPs was confirmed. 
Applications of IONPs in vitro and in vivo always include high dilutions of NPs dispersions, 
also, stability under high salt concentrations and over a range of pHs must be retained22. Therefore, 
IONPs required sufficient stability to endure long circulation time in bio media. For approve the 
enhanced stability of CLNPs, three compositions of NPs were dispersed in broad range of pH (pH 
3-11) solution and measured changes of sizes with DLS for a week (figure 14). The cross-linking 
condition used in this experiment was the most stable 250 eq. of HDM condition among the three 
diamines identified in the previous experiment. In the case of IONPs composed of DMA30% 
PEG48070% ligand (IONPs-PEG) (figure 14a), IONPs-PEG became unstable at pH 3 buffer solution 
after 1day, as shown in camera image, aggregates occurred after one week. The size of IONPs-PEG 
measured with DLS was significantly increased. In the case of IONPs composed of DMA30% 
PEG48040% Acrylic acid30% ligand (IONPs-AA) (figure 14b), also became unstable in pH 3 
buffer solution. However, there was a difference from the IONPs-PEG condition. This result 
indicates the negative charge of acrylic acid assisted dispersion in buffer solution with charge 
repulsion. Unlike the other IONPs, CLNPs stayed stable in all of pH range for a week because of 
cross-linking reaction ensured stability of IONPs (figure 14c). stability of IONPs dispersions to 
excess electrolytes (NaCl) exhibited a similar trend (figure 15). In the case of IONPs-PEG became 
unstable after 1 day in high concentration of NaCl (3 M), DLS measurement result shows that the 
size of IONPs-PEG was dramatically increased after 1 day in all concentrations of NaCl conditions 
(figure 15a). As similar with the previous results, IONPs-AA was more stable than IONP-PEG in 
NaCl solution (figure 15b). This is also the result of charge repulsion due to the acrylic acid 
negative part. Still, became unstable in high concentration of NaCl solution (3 M). To overcome 
these unstable conditions, CLNPs retained their size in NaCl at each concentration, which proved 
the stability of CLNPs (figure 15c). In addition, unlike previous studies, the size variation of IONPs 
under various conditions was studied in detail and stability of IONPs was compared. 
Since the stability was improved, an experiment was conducted to confirm that it was stable 
in further reaction. For bio application of NPs, the general conjugation method called ‘click’ 
chemistry is used for conjugation of bio molecules to NPs because of its rapid, specific, and robust 
conjugation reaction. However, the ‘click’ chemistry reaction takes place under harsh conditions 
such as of 1 mM of copper sulfate and 5 mM of ascorbic acid solution. So, it is a challenge to be 
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stable in the harsh condition for conjugation of bio molecules. These difficulties can be 
complemented by CLNPs (figure 16). As shown in the figure, IONPs and CLNPs were compared 
the stability in the ‘click’ chemistry reaction condition. In the case of IONPs, which were uncross-
linked, all degradation occurred and precipitated were formed (figure 16a). Unlike this, CLNPs 
were stable and change of size was not observed after 24 hr (figure 16b, d). These results suggest 
that bio-application without any aggregation is possible even with application of CLNPs to the 
azide-alkyne conjugation method. The stability at high temperature was confirmed by treated 
IONPs in 95℃ of oil bath (figure 16e). Only the size of IONPs-PEG was increased after treated 
several minutes. On the other hand, IONPs-AA stayed stable as CLNPs, the reason for this result 
is that the partial acid part of acrylic acid has a role on the surface to some extent. Finally, the 
stability in purification step was compared. Also, the similar result was exhibited that as the number 
of viva spin increases, only IONPs-PEG became unstable (figure 16f). These various tools were 








Figure 14. Camera image of stability of (a) IONPs-PEG (c) IONPs-AA and (e) CLNPs in wide range 
of pHs. Graph of hydrodynamic diameter about time consuming results in various pHs (b) IONPs-PEG 




















Figure 15. Camera image of stability of (a) IONPs-PEG (c) IONPs-AA and (e) CLNPs in various 
concentrations of NaCl solutions. Graph of hydrodynamic diameter about time consuming results in 


















Figure 16. Stability test in click chemistry conditions with (a) IONPs-PEG (b) CLNPs (c) 24 h later 
in click chemistry condition IONPs-PEG (left) and CLNPs (right) and (d) measured with DLS. (e) 
stability test of thermal effect in 95 °C condition. (f) hydrodynamic diameters were measured to 






2.3.5 Multifunctional conjugation of CLNPs 
Functional groups of NPs are essential for bio application such as cancer cell targeting and 
drug delivery62-63. CLNPs are multifunctional nanoparticles with stability and functionalization 
characteristics at the same time. In previous experiments, as the amine functionalization of CLNPs 
were confirmed by RITC conjugation (figure 9). With this known accessible amine group of CLNPs, 
several bio molecules were conjugation experiments were performed (scheme 5). 
First, one of the monosaccharide types, mannose (Man) was conjugated to CLNPs for 
confirmation of amine functionalization. This glycoconjugates such as mannose, glucose, and 
galactose are attractive substance for targeting receptor-mediated interaction. It has advantages of 
easy synthesis process and targeting ability with specific lectins64. To conjugated thiolated mannose 
(Man-SH) to amine functionalized CLNPs, the linker was essential for maleimide-thiol specific 
conjugation (scheme 5a). After CLNPs-Man conjugation, dialysis at pH 11 buffer process was 
necessary for deprotection of acetyl protected group of Man, solvent exchange, and purification of 
excess molecules. After all processes and re-dispersed in 1xPBS buffer, the size of CLNPs-Man 
was compact without any aggregates (figure 17). The conjugation of CLNPs-Man was analyzed by 
High resolution magic angle spinning (HR-MAS) (figure 18). Signal from 3.5 - 3.6 ppm indicates 
specific peak of mannose. To separate signal for more detailed analysis, the signal 3.65 ppm 
indicates the organic ligand of CLNPs. Further analysis was performed with Fourier transform 
infrared (FT-IR) (figure 19). The O-H bond from carboxyl group wavelength from 920 - 990 cm-1 
decreases in CLNPs-Man signal, also the appearance of amide peak 1650-1720 cm-1 indicates 
cross-linked part. In addition, 1248 cm-1 C-N peak was identified as maleimide group and sulfide 
bond from Man-SH maleimide conjugates was identified in wavelength 604 cm-1. 
Based on the above conjugation result, another bio molecule called folic acid was conjugated 
to CLNPs (scheme 5b). Folic acid has strong binding affinity with folate receptor which expressed 
in human malignant cell membranes such as cancers of ovary, kidney, lung, breast, and liver. When 
folic acid conjugated NPs bind to the folate receptor, cell targeting occurred by the endocytosis45, 
65. With this properties and advantages of inexpensive and stable in bio media, it’s application of 
NPs are widely researched for decades. After conjugation of folic acid to CLNPs process, the size 
of CLNPs-FA seemed to maintain stable HD size ~24 nm without any aggregation (Figure 20a). 
UV-Vis analysis was used for confirmation of CLNPs-FA (figure 20b). Since the folic acid has 
specific absorbance in wavelength 285 and 360 nm, this specific peak was observed in CLNPs-FA 
UV-Vis graph. In the case of CLNPs, the dopamine peak at 280 nm was observed but nothing at 
360 nm. With this result, CLNPs-FA were formed successfully and indicates that CLNPs are highly 




















































Figure 18. HR-MAS data of CLNP-Man (red), Man-SH (yellow), Polymer ligand (green), and Acetyl 






















































Figure 20. (a) DLS data of after folic acid conjugated to CLNPs (b) UV-Vis absorbance analysis to 





2.3.6 specific targeting test by MR relaxivity 
Although CLNPs-Man were synthesized, it is important to that the carbohydrates immobilized 
on CLNPs retain their biological recognition specificity. This was proved using addition of 
mannose specific recognized lectin Concanavalin A (Con A) into CLNPs-Man. This process was 
measured by magnetic resonance relaxivity through Minispec analysis. It is well known that since 
the magnetic moment of a nanoparticle is proportional to its volume, the R2 relaxivity increases 
with IONPs size7. Based on this background, when IONPs become agglomerate like cluster form, 
the local magnetic field gradients increases at the same time, so surrounding water molecules spin 
dephasing occurred efficiently66-67. Because of these characteristics, T2 relaxation time is reduced 
and the contrast effect is increased and it will appear darker imaging on MRI (scheme 6).  
First, upon incubation of a Con A lectin with IONPs and CLNPs-Man, confirmed that mannose 
conjugated to CLNPs was retained its biological recognition. Significant decrease of T2 relaxation 
value was observed in CLNPs-Man (Figure 21a). This is because that Con A has four binding sites 
for mannose conjugation, so when CLNPs-Man interacted with Con A, CLNPs became 
agglomerated which effect decrease of T2 relaxation time. Unlike CLNPs-Man, CLNPs without 
mannose have no change in T2 relaxation after addition of Con A (Figure 21a). To further validate 
the specificity, glucose specific recognition lectin wheat germ agglutinin (WGA) lectin was used 
instead of Con A (figure 21b). As shown in the graph, there was no difference in T2 relaxation time 
when the WGA was added to CLNPs-Man while Con A was effective. Through these results, 
mannose which immobilized in CLNPs retain their biological recognition specificity, indeed, 










Scheme 6. Scheme of CLNPs-Man incubated with Con A resulted in the formation of aggregates, 
































Figure 21. Graph of MR T2 relaxivity (a) with addition of Con A to CLNP (blue) and CLNP-Man (red). 
(b) changes of T2 relaxivity of CLNPs-Man using different lectins Con A(red) and WGA (blue). 
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2.3.7 In vitro test with folic acid conjugated CLNPs 
As shown in the above experiment, since it was confirmed that the bio molecules retain their 
characteristics even after conjugation, folic acid was conjugated to CLNPs for in vivo targeting test. 
Folic acid mediated in vitro targeting experiment was performed in HeLa cell. Characterized 
CLNPs-FA (figure 20b) and normal CLNPs were incubated to HeLa cell for 6 hours. In this case, 
the concentrations of NPs were set to 200 and 500 uM. To verify cellular uptake of IONPs, Prussian 
blue staining method is mainly used because Prussian blue can be reacted with magnetite core, then 
the intense blue color can be performed68. After Prussian blue staining, the HeLa cell was observed 
with inverted fluorescence microscopy (figure 22). There was no blue staining in HeLa cells treated 
with normal CLNPs, while CLNPs-FA treated HeLa cells were stained in blue as the result of highly 
specific targeting and uptake by folate receptor. These results indicate folic acid presented in 

















Figure 22. Microscopy image of Prussian blue stained HeLa cell treated with (a) 200 uM and (c) 500 




In this research, highly stable and amine functionalized compact IONPs were developed by 
cross-linking reaction with EDC coupling. Firstly, ligand of the composition suitable for uniform 
IONPs was synthesized. The ligand was composed of catechol dopamine methacrylamide (DMA) 
which has strong binding affinity with iron ion, poly(ethylene glycol) (PEG) as hydrophilic part, 
and carboxyl acid as functional group by RAFT polymerization system. Through this optimization 
experiment, the ligand composited DMA 30% PEG480 40% AA 30% was used for ligand 
exchanged with coating reagent AEE to impart compact thin coating and hydrophilic function of 
IONPs. Furthermore, effect of cross linking by EDC coupling using various lengths of diamines 
was performed, and compared the stability difference and the degree of amine functionalization in 
IONPs. 
Also, in this research, proposed a means to clearly compare the stability of the CLNPs by 
confirming the stability of the CLNPs through various tools such as XPS spectra, TEM 
visualization, click chemistry condition, time consuming size change in wide range of pHs and 
NaCl. Moreover, the fact CLNPs were highly stable in click chemistry condition, indicates 
possibility of azide-alkyne bio molecules conjugation system can be applied to CLNPs process for 
rapid and rigid conjugation. As high stability was established, CLNPs have amine functional group 
at the same time. To confirm these amine groups are available for bio conjugation, mannose and 
folic acid were conjugated. After all of procedures, there was no aggregation of CLNPs conjugates, 
and characterized with HR-MAS, FT-IR, and UV-Vis. MR imaging and cancer cell targeting test 
showed that the conjugated bio molecules retained their properties after conjugation to CLNPs. 
Through these sufficient proofs of CLNPs bio applications, NPs based on this nano-platform 
system have potential to being applied to real bio applications such as drug delivery, MR imaging, 
and hyperthermia therapy. 
By developing the platform that can enhance the stability of the NPs and facilitate the 
functionalization by the simple cross-linking method, it is expected that can facilitate the bio 
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